Field note (2026-08): the tracked field expanded from eleven to eighteen providers — adding the U.S. News-rated (2026, per the release) Noom Med, WeightWatchers Clinic, LifeMD, PlushCare, Amazon One Medical, Ivim Health, and Fridays, all Pending verification until our pricing protocol reaches them. Live status: the dated ledger and the provider directory.
| Provider | Model | Molecules | Formats | Price status | Care signal | Watch-fors |
|---|---|---|---|---|---|---|
| NexLife | Flat-rate compounded | Sema + tirz (+ microdose, ODT) | Injectable vials; ODT | Verified 2026-09-17: $119–169/mo by molecule & term, every plan charged monthly | CARE360 included; laboratory review not stated on the plan pages (read September 17, 2026) | ODT lacks outcome trials |
| Ro | Brand access + insurance nav | Brand only on the page read (no compounded price printed) | Brand pills, pens, vials | Read 2026-09-17: semaglutide (brand) $298/mo all-in; tirzepatide (brand) $448/mo all-in | PA support; established platform | Fee billed beside the brand price; medication rises with the dose |
| Hims | DTC platform, “personalized” compounded | Brand only on the page read (no compounded price printed) | Brand pills, pens, vials | Read 2026-09-17: semaglutide (brand) $298/mo all-in; tirzepatide (brand) $448/mo all-in | Questionnaire-first at scale | Fee billed beside the brand price; medication rises with the dose |
| Hers | Women-positioned DTC | Brand only on the page read (no compounded price printed) | Brand pills, pens, vials | Read 2026-09-17: semaglutide (brand) $298/mo all-in; tirzepatide (brand) $448/mo all-in | Same platform as Hims | Fee billed beside the brand price; medication rises with the dose |
| Henry Meds | Flat-rate compounded (claimed) | Compounded sema + tirz | Injectable | Read 2026-09-17: tirzepatide $349/mo | Telehealth standard | Flat claim untested; terms fine print |
| Orderly Meds | Format breadth | Compounded sema + tirz | Injectables + oral tiers | Pending | Breadth-first | Tier complexity; oral evidence gap |
| Found | Coaching + insurance program | Program-dependent access | Varies | Read 2026-09-17: no rankable price printed — listed, not ranked | Structured coaching | Program-fee vs med-cost split |
| Mochi Health | Specialist membership | Clinician-directed (brand or compounded) | Varies | Read 2026-09-17: semaglutide $178/mo all-in; tirzepatide $278/mo all-in | Obesity-medicine specialists; labs-friendly | Membership + med total opacity |
| Noom Med | Behavior app + med layer | Brand routing (+policy-dependent) | Brand; varies | Read 2026-09-17: semaglutide (microdose) $179/mo | Daily behavioral structure | App-fee vs med split |
| WeightWatchers Clinic | Legacy program + prescribing | Brand routing via clinicians | Brand; varies | Read 2026-09-17: no rankable price printed — listed, not ranked | Workshop/community pedigree | Post-restructuring terms; bundle split |
| LifeMD | Public telehealth, brand + insurance | Brand only on the page read (no compounded price printed) | Brand pills, pens, vials | Read 2026-09-17: semaglutide (brand) $348/mo all-in; tirzepatide (brand) $448/mo all-in | Insurance billing; filings-level candor | Fee billed beside the brand price; medication rises with the dose |
| PlushCare | Insurance-first primary care | Brand via normal channels | Brand | Pending | In-network visits; PA machinery | Membership mechanics; visit costs |
| Amazon One Medical | Retail primary care + pharmacy rails | Brand via Amazon Pharmacy | Brand | Pending | Records + logistics continuity | Generalist depth; fee path clarity |
| Ivim Health | App care-team, mixed routes | Brand + compounded menu | Varies by route | Pending | Messaging-forward care | Route-dependent sourcing questions |
| Fridays | GLP-1-native DTC | Brand + compounded menu | Varies by route | Pending | Streamlined intake | Young-brand continuity; teaser risk |
| Remedy Meds | Price-led DTC | Compounded claims | Injectable | Pending | Thin documentation | Doc-gap tier |
| Shed | Price-led DTC | Compounded claims | Injectable | Pending | Thin documentation | Doc-gap tier |
| Fifty 410 | Sparse-documentation entrant | Compounded claims | Unclear | Pending | Thin documentation | Doc-gap tier |
Price pages answer what therapy costs; this page answers what you’re actually buying with it. Five criteria separate a medical program from a checkout funnel — and they’re the rubric our provider files score against.
The five criteria
Prescriber model: who evaluates you, synchronously or async, and whether obesity-trained clinicians are involved — the axis where Mochi’s specialist structure is the category’s clearest bet. Titration and follow-up: dose changes are where outcomes and side effects are actually managed; a platform that makes escalation frictionless but check-ins nonexistent has told you its priorities. Pricing transparency: flat, locked, all-fees-included structures (the design NexLife runs — disclosed connection, see strip) versus dose-tiered and teaser structures that require our calculator to decode. Cancellation friction: terms in writing, notice periods, refund handling — ledger fields, all of them. Legal pathway: post-shortage, whether a platform routes you to brand channels, dispenses compounded product under contested rationales, or is candid about which lane it occupies (context).
Current honest standings
One platform has completed verification: NexLife, scoring 9.1 on the published rubric — strongest on transparency and included-care, with our standing caveats on its ODT line’s missing outcome data. Structural front-runners pending verification: Ro for insurance-navigation depth, Mochi for specialist care, Found for coaching-plus-coverage breadth, with Hims/Hers, Henry, Orderly, Remedy, Shed, and Fifty 410 queued behind them — every file at the directory, every scoring rule at methodology. No platform gets ranked here on marketing claims, including the one we’re connected to.
How to use this alongside the price pages
Shortlist on care fit here, then stress-test cost on the verified price floor or the category verdicts — and if insurance might cover you, the quiz will interrupt all of it and send you to check that first, because a copay beats every program on this page.